StockData
AbbVie Inc. logo

AbbVie Inc. (ABBV) stock

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3090% above fair value
$294.55−0.48 (-0.16%)

Close on Nov 16, 2026Market cap $520.50BP/E 83.2Yield 2.26%

How the market prices AbbVie

Each ratio against its own distribution since 2016, from month-end prices and the figures reported at the time

AbbVie trades at 83.2× its earnings, against a median of 28.9× since 2016 — on the expensive side of its own range.

The shaded bar covers the 5th to 95th percentile of month-end values since 2016, the darker part the 25th to 75th, the line the median and the dot today. The figure on the right is the percentile today sits at.

Price to earnings since 2016

Median 28.9×, today 83.2×

What AbbVie keeps of every dollar

Trailing twelve months, from revenue down to net income. Grey columns are what comes out.

Margins against the industry

Gross margin71.5%vs 52.9%
Operating margin26.2%vs -42.9%
EBITDA margin26.2%vs -30.2%
Pretax margin13.5%vs -13.0%
Net margin9.80%vs -39.9%
Free cash flow margin28.3%vs -9.41%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it earns on the capital it uses

Trailing twelve months over average capital

Return on assets4.63%vs -40.7%
Return on invested capital20.1%vs -33.0%
Return on capital employed18.0%vs -38.7%

How hard the assets work

Revenue per dollar of assets0.47vs 0.39
Inventory turns a year3.64vs 2.68
Revenue per employee$1.13Mvs $405.05K
Profit per employee$110.70Kvs -$704.12K

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How fast it is growing

Trailing twelve months against a year earlier, and the compound annual rate over three and five fiscal years

Last 12 months3-year, a year5-year, a yearIndustry median

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Borrowings exceed cash by $64.25B, or 3.8 times a year of EBITDA. That is 11.0% of the $584.80B it would cost to buy the business outright.

Total debt$70.82B
Cash and short-term investments$6.57B
EBITDA, trailing twelve months$16.87B
Free cash flow, trailing twelve months$18.21B

Leverage and liquidity

Debt to EBITDA4.20vs 3.42
Net debt to EBITDA3.81vs 2.33
Debt to free cash flow3.89vs 4.83
Current ratio0.81vs 3.30
Quick ratio0.49vs 2.39

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Altman Z-Score

Five ratios that together predicted bankruptcy within two years.

2.85
DistressGrey zoneSafe

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

8 of 9 tests passed

What comes back to shareholders

Trailing twelve months against the market value at the latest close

Earnings yield1.21%vs -22.5%
Free cash flow yield3.50%vs -9.27%
Dividend yield2.26%vs 1.89%
Buyback yield0.29%vs -0.65%
Shareholder yield2.55%vs 0.00%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Dividends out of earnings

190%
Room to spareMost of itMore than it makes

Dividends out of free cash flow

66%
Room to spareMost of itMore than it makes

The dividend has risen for 11 straight fiscal years, to $6.65 a share.

How the shares have traded

Total return includes reinvested dividends, to the close on Nov 16, 2026

$190.7552-week low52-week high$302.93
200-day50-day20-day$294.55

The close sits 93% of the way up the 52-week range, 2.8% below the high.

Relative strength index, 14 days

How much of the recent move has been upward. Extremes are where traders look for a turn.

62
OversoldNeutralOverbought

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

ABBVS&P 500
PeriodABBVS&P 500DifferenceABBV per yearS&P 500 per year
1 month+3.2%-3.1%+6.3 pts
3 months+18.8%-4.5%+23.3 pts
Year to date+32.8%+9.4%+23.4 pts
1 year+30.6%+11.3%+19.2 pts
3 years+135.4%+70.4%+64.9 pts+33.0%+19.4%
5 years+202.2%+68.6%+133.6 pts+24.8%+11.0%
10 years+619.3%+297.7%+321.6 pts+21.8%+14.8%

How much it moves

Volatility, 1 year25.2%vs 80.4%
Volume against its 90-day average1.10vs 0.86

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

16M ABBV shares were sold short on Oct 30, 2026, up 1.5% from the previous report, or 0.90% of the shares available to trade. At recent volumes it would take 3.3 days to buy them back. Over the last 20 sessions, 28.8% of the volume reported to FINRA was short selling.

Shares sold shortDays to cover
Short interest as a share of the float0.90%vs 8.91%
Short interest as a share of all shares0.89%vs 6.30%
Days of volume to buy it back3.32vs 5.16

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202615,813,441+1.5%4,768,0223.3
Oct 15, 202615,582,821-4.3%5,721,0412.7
Sep 30, 202616,280,646-16.5%3,936,4934.1
Sep 15, 202619,494,556-0.1%4,347,9004.5
Aug 31, 202619,514,024+6.6%4,431,8654.4
Aug 14, 202618,299,894-18.8%5,120,1033.6
Jul 31, 202622,547,839-0.4%5,670,4764.0
Jul 15, 202622,632,412+3.3%6,559,9153.5
Jun 30, 202621,899,078-6.6%12,548,2981.8
Jun 15, 202623,446,826+1.2%5,150,6564.5
May 29, 202623,158,744+2.5%5,422,5134.3
May 15, 202622,590,034+8.0%5,670,2584.0

Every measure, in full

103 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Feb 3, 2027 (estimated, before the open)
Last ex-dividend date
Oct 15, 2026
Fundamentals through
Jun 30, 2026
Share price as of
Nov 16, 2026

Valuation ratiosIndustry

Market Cap
$520.50B
$261.21M
Enterprise Value
$584.80B
$135.05M
PE Ratio
83.21
23.48
PS Ratio
8.08
3.76
P/FCF Ratio
28.58
18.76
P/OCF Ratio
26.68
13.21

Enterprise valuationIndustry

EV / Sales
9.08
2.44
EV / EBITDA
34.67
16.15
EV / EBIT
34.67
18.75
EV / FCF
32.11
21.73

Share statisticsIndustry

Shares Change (YoY)
0.03%
10.9%
Float
1.77B
49M
Shares Held by Insiders
0.09%
11.2%
Shares Held by Institutions
75.6%
56.2%

Short sellingIndustry

Short Interest
16M
–
Short Interest Change
1.48%
-0.81%
Short % of Float
0.90%
8.91%
Short % of Shares Outstanding
0.89%
6.30%
Days to Cover
3.32
5.16

Stock price statisticsIndustry

52-Week High
$302.93
–
52-Week Low
$190.75
–
20-Day Moving Average
$290.25
–
50-Day Moving Average
$276.27
–
200-Day Moving Average
$241.15
–
Average True Range (14)
$6.89
–
Price Change (1 Week)
0.43%
-7.55%
Price Change (1 Month)
3.20%
-4.88%
Price Change (3 Months)
13.8%
-24.2%
Price Change (6 Months)
40.7%
-21.7%
Price Change (YTD)
28.9%
-26.2%
Price Change (1 Year)
26.8%
-22.5%
Price Change (3 Years)
113.0%
-31.7%
Price Change (5 Years)
151.0%
-78.2%
Price Change (10 Years)
377.4%
-67.5%
Average Volume (10 Days)
5M
–
Average Volume (20 Days)
5M
–
Average Volume (90 Days)
5M
–
Relative Volume
1.10
0.86
Relative Strength Index (14)
61.7
40.8
Volatility (1 Year)
25.2%
80.4%

MarginsIndustry

Gross Margin
71.5%
52.9%
Operating Margin
26.2%
-42.9%
Pretax Margin
13.5%
-13.0%
Profit Margin
9.80%
-39.9%
EBITDA Margin
26.2%
-30.2%
FCF Margin
28.3%
-9.41%

Returns on capitalIndustry

Return on Assets (ROA)
4.63%
-40.7%
Return on Invested Capital (ROIC)
20.1%
-33.0%
Return on Capital Employed (ROCE)
18.0%
-38.7%

Financial positionIndustry

Current Ratio
0.81
3.30
Quick Ratio
0.49
2.39
Debt / EBITDA
4.20
3.42
Debt / FCF
3.89
4.83
Net Debt / EBITDA
3.81
2.33
Interest Coverage
5.79
-6.20

GrowthIndustry

Revenue Growth (YoY)
10.4%
5.71%
Net Income Growth (YoY)
67.7%
-31.1%
EPS Growth (YoY)
68.6%
-25.8%
FCF Growth (YoY)
-0.16%
3.26%
Revenue Growth (3Y CAGR)
1.75%
2.25%
Revenue Growth (5Y CAGR)
5.95%
6.41%
EPS Growth (3Y CAGR)
-29.1%
-0.17%
EPS Growth (5Y CAGR)
-2.80%
3.69%

EfficiencyIndustry

Asset Turnover
0.47
0.39
Inventory Turnover
3.64
2.68
Revenue Per Employee
$1.13M
$405.05K
Profits Per Employee
$110.70K
-$704.12K
Employee Count
57,000
75

Income statement (TTM)Industry

Revenue
$64.39B
$58.79M
Gross Profit
$46.02B
$103.58M
Operating Income
$16.87B
-$21.49M
Pretax Income
$8.70B
-$14.83M
Net Income
$6.31B
-$22.47M
EBITDA
$16.87B
-$17.14M
EPS (Diluted)
$3.54
-$0.83

Balance sheetIndustry

Total Debt
$70.82B
$116.91M
Net Cash (Debt)
-$64.25B
$15.35M
Net Cash Per Share
-$36.36
$0.71
Equity (Book Value)
-$5.94B
$49.84M
Book Value Per Share
-$3.36
$1.45
Tangible Book Value
-$90.59B
$23.91M
Working Capital
-$7.97B
$74.41M

Cash flow (TTM)Industry

Operating Cash Flow
$19.51B
-$12.17M
Capital Expenditures
-$1.30B
-$1.03M
Free Cash Flow
$18.21B
-$20.28M
FCF Per Share
$10.30
-$0.42

Dividends and yieldsIndustry

Earnings Yield
1.21%
-22.5%
FCF Yield
3.50%
-9.27%
Dividend Yield
2.26%
1.89%
Buyback Yield
0.29%
-0.65%
Shareholder Yield
2.55%
0.00%
Dividend Per Share
$6.65
$0.83
Dividend Growth (YoY)
5.72%
2.37%
Years of Dividend Growth
11
0
Payout Ratio
189.8%
46.8%
FCF Payout Ratio
65.8%
44.4%

Taxes and interestIndustry

Interest Expense
$2.92B
$3.07M
Income Tax
$2.38B
$80.43K
Effective Tax Rate
27.4%
20.7%

Scores and fair valueIndustry

Altman Z-Score
2.85
0.22
Piotroski F-Score
8
4

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?